Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy

World Journal of Surgery

Volumn 29, Issue 10, 2005, Pages 1325-1328

  Hesse, Uwe J ^a,b   DeDecker, Christophe ^a   Houtmeyers, Philippe ^a   Demetter, Pieter ^a   Ceelen, Wim ^a   Pattyn, Piet ^a   Troisi, Roberto ^a   DeHemptinne, Bernard ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Klinikum Stuttgart Krankenhaus Bad Cannstatt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART ARREST; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; ORGAN INJURY; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREAS SURGERY; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PANCREATICOJEJUNOSTOMY; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PYLORUS; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SURGICAL DRAINAGE; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL TECHNIQUE; URINARY TRACT INFECTION;

AGED; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PANCREAS; PANCREATICOJEJUNOSTOMY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 27744558579     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-7546-1     Document Type: Article

References (18)

1. Van Berge Henegouwen MI, Moojen TM, Van Gulik TM, et al. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumor status. Br. J. Surg. 1998;85:922-926
2. Neoptolernos JP, Russell RC, Bramhall S, et al. Low mortality following resection for pancreatic and periampullary tumors in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br. J. Surg. 1997;84:1370-1376
3. Trede M, Saeger HD, Schwall G, et al. Resection of pancreatic cancer - surgical achievements. Langenbecks Arch. Surg. 1998;383:121-128
4. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann. Surg. 1993;217:430-435
5. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomiesin the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997;226:248-257
6. Fernandez-del Castillo C, Rattner DW, Warschaw AL. Standards for pancreatic resection in the 1990s. Arch. Surg. 1995;130:295-299
7. Trede M, Carter DC. The complications of pancreatoduodenectomy and their management. In: Trede, M, Carter, DC, Surgery of the Pancreas. Edinburgh: Churchill Livingstone, 1993, pp 629-644
8. Gouillat C, Chipponit J, Baulieux J, et al. Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy. Br. J. Surg. 2001;88:1456-1462
9. Büchler M, Friess H, Klempa, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am. J. Surg. 1992;163:125-130
10. Pederzoli P, Bassi C, Falconi M, et al. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br. J. Surg. 1994;81:265-269
11. Lowy AM, Lee JE, Pisters PW, et al. Prospective randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann. Surg. 1997;226:632-641
12. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann. Surg. 2000;232:419-429
13. Schäfer M, Müllhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann. Surg. 2002;236:137-148
14. Li-Ling J, Irving M. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br. J. Surg. 2001;88:190-199
15. Friess H, Beger HG, Sulkowski U, et al. Randomized controlled mulicentre study on the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br. J. Surg. 1995;82:1270-1273
16. Suzuki Y, Fujino Y, Tanioka Y, et al. Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch. Surg. 2002;137:1044-1047
17. Büchler W, Friess H, Wagner M, et al. Pancreatic fistula after pancreatic head resection. Br. J. Surg. 2000;87:883-889
18. Heintges T, Luthen R, Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion 1994;55:1-9